Lynn LaPierre is a New York-based consultant and leader of Spencer Stuart’s Global Biopharma Practice. Lynn has more than 20 years of experience working in the pharmaceutical and pharmaceutical services industries as a researcher, attorney, and commercial leader. Lynn works on searches for boards, and commercial, corporate development, and medical affairs leadership for clients ranging from global corporations to fast-growing companies.

Extensive experience in pharma and pharma services settings

  • Prior to joining Spencer Stuart, Lynn served as executive director for another global executive search firm.
  • Lynn also led the global life sciences practice at Axiom, a technology-enabled professional services company serving Fortune 1000 clients.
  • Before that, Lynn was a product liability litigator and then served as senior counsel at Catalent Pharma Solutions.
  • Lynn also spent time as a cognitive neuroscience researcher at both the Mount Sinai School of Medicine and Harvard Medical School studying breast cancer genetics and the pathophysiology of schizophrenia.

Lynn has a bachelor’s degree in business from Cornell University, a master’s degree in neuropsychology from Columbia University and a juris doctor from Boston College where she was an Albert Schweitzer Fellow.

Practice Areas